Actinic Keratosis

Latest News

Imiquimod Capable of Detecting Subclinical Actinic Keratosis
Imiquimod Capable of Detecting Subclinical Actinic Keratosis

August 24th 2023

As few as 90% of study participants without visible actinic keratosis lesions displayed inflammatory reactions indicative of the presence of subclinical AK lesions.

CRH-R1 Markedly Increased in Psoriasis, Actinic Keratosis Mast Cells
CRH-R1 Markedly Increased in Psoriasis, Actinic Keratosis Mast Cells

August 22nd 2023

Lesions of actinic keratosis or sunspots on sun-damaged skin of the hand of a man
PROAK Study: Tirbanibulin Boosts Quality of Life for Patients With Actinic Keratosis

February 18th 2023

Tirbanibulin Improves Skin in Patients with Actinic Keratosis
Tirbanibulin Improves Skin in Patients with Actinic Keratosis

February 12th 2023

skin cancer
Skin Cancer and the Cutaneous Microbiome: Thinking Small May Produce Big Results

April 13th 2022

Video Interviews
Latest CME Events & Activities

Medical Crossfire®: Diagnostic and Clinical Considerations in Cutaneous T-Cell Lymphoma for the Dermatologist and the Collaborative Cancer Team

View More

Expert Illustrations and Commentaries™: A Deeper Look at the Pathogenesis of Hidradenitis Suppurativa (HS)

Register Now!

Best Practice in the Multidisciplinary Care of the Patient with HS

View More

Addressing Challenges in the Management of HS in Special Populations

View More

Patient, Provider, and Caregiver Connection™: Incorporating the Patient Journey into HS Diagnosis and Management Practices

View More

Cases and Conversations™: Enhancing Diagnosis and Evaluation of Generalized Pustular Psoriasis in Advanced Practice Settings

View More

Community Practice Connections™: Multidisciplinary Management of BPDCN: Strategies for Differential Diagnosis and Integrating Novel Targeted Therapy

View More

Clinical ShowCase™ in Atopic Dermatitis: Personalized Management Plans for Pediatric Patients

View More

20th Annual International Symposium on Melanoma and Other Cutaneous Malignancies®

View More

Facing the Changing Landscape for Neuromodulators and Dermal Fillers

View More

Advances In: Integrating New Treatment Options into Management Plans for Patients with Moderate-to-Severe Atopic Dermatitis

View More

Medical Crossfire®: Maximizing Patient Outcomes in Shingles – Are You Leveraging Guideline Based Care?

View More

"REEL" Time Patient Counseling™: Integrating Biosimilars into the Clinical Conversation

View More

PER Skin Summit: Optimizing Diagnosis and Individualizing Management of Hidradenitis Suppurativa

View More

More News

© 2023 MJH Life Sciences

All rights reserved.